B
Beam Therapeutics
BEAM
30.330
USD
-1.31
(-4.14%)
مفتوح الان
حجم التداول
6,357
الربح لكل سهم
0
العائد الربحي
0
P/E
-14
حجم السوق
1,860,944,677
الأخبار
العنوان: Beam Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making adouble-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.